Ottimo ma..
Da aggiornare!!
Ottima!
Utile per districarsi nel mondo dei Nao, soprattutto per chi è alle prime armi!!!
Ottima
Precisa puntuale ed utilissima
Free
About
This medical app helps healthcare professionals determine the appropriate dosage and prescription for new oral anticoagulants (NOACs) like dabigatran, rivaroxaban, apixaban, and edoxaban. It focuses on adult patients with non-valvular atrial fibrillation and at least one risk factor for stroke.
✓NOAC prescriber identification
✓Dosage calculation
✓Dabigatran, Rivaroxaban, Apixaban, Edoxaban
✓Adult patients with AFib
✓Stroke risk factor assessment
Show original description
What's New in NAO
1.8
November 1, 2017
Quest’app è stata aggiornata da Apple per visualizzare l’icona dell’app di Apple Watch. informazioni su tromboembolismo venoso
MoreUser reviews
Developer apps
FAQ
What is NAO used for?
NAO helps healthcare professionals identify the correct prescription and dosage for new oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban, and edoxaban in adult patients with non-valvular atrial fibrillation.
Which NOACs does NAO cover?
NAO covers dabigatran, rivaroxaban, apixaban, and edoxaban, which are the NOACs currently approved in Europe and the United States.
Who is the target patient for NAO?
The app is designed for adult patients diagnosed with non-valvular atrial fibrillation who also have at least one identified risk factor for stroke.
Is NAO available on Android devices?
Based on the provided data, NAO is currently supported on iPhone and iPod devices. Android compatibility is not specified.
How often is NAO updated?
The latest version of NAO was released on November 1, 2017, indicating it was last updated on that date. The frequency of future updates is not detailed.
What is the age rating for NAO?
NAO has an age rating of 17+, suggesting it is intended for use by healthcare professionals and older individuals.
Does NAO have ads?
No, NAO does not contain advertisements. The app is free to download and use without any ad interruptions.
What is the developer of NAO?
NAO is developed by ANMCO (ASSOCIAZIONE NAZIONALE MEDICI CARDIOLOGI OSPEDALIERI), an association of hospital cardiologists.
